Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Aug 7, 2022; 28(29): 3934-3945
Published online Aug 7, 2022. doi: 10.3748/wjg.v28.i29.3934
Table 1 Characteristics data for all patients
Characteristics, n (%)
Total (n = 1305)Grade I (n = 433)Grade II (n = 405)Grade III (n = 467)P value
Age (yr)-median (IQR)74 (63-82)66 (59-72.5)79 (69-84)77 (66-83)< 0.001
Male, n (%)783 (60)276 (63.7)240 (59.3)267 (57.2)0.123
CCI- median (IQR)2 (1-4)2 (1-3)2 (1-4)3 (1-5)< 0.001
Etiology, n (%)< 0.001
Choledocholithiasis906 (69.4)315 (72.7)252 (62.2)339 (72.6)
Malignant obstruction242 (18.5)73 (16.9)97 (24.0)72 (15.4)
Benign stenosis94 (7.2)27 (6.2)42 (10.4)25 (5.4)
Others63 (4.8)18 (4.2)14 (3.5)31 (6.6)
Biliary drainage, n (%)915 (70.1)302 (69.7)306 (75.6)307 (65.7)0.006
LOS (d)-median (IQR)11 (8-14)11 (8-14)11 (7.5-14)12 (7-15)0.110
Hospitalization cost (CNY)-median (IQR)38784.37 (22744.31-53278.63)36536.36 (20851.37-47274.77)38308.33 (23452.14-52847.29)41832.19 (23355.98-58145.52)< 0.001
IHM, n (%)41 (3.1)1 (0.2)7 (1.7)33 (7.1)< 0.001
Survival time of dead (d)-median (IQR)8 (3-23.5)923 (13-46)6 (3-17)0.024
Organ dysfunction
Neurological dysfunction12600126< 0.001
Respiratory dysfunction22700227< 0.001
Renal dysfunction640064< 0.001
Cardiovascular dysfunction390039< 0.001
Hematological dysfunction14900149< 0.001
Hepatic dysfunction830083< 0.001
Temperature (℃)-median (IQR)37.0 (36.6-38)36.8 (36.6-37.8)37 (36.6-38.25)37.2 (36.6-38.3)0.001
Laboratory values
WBC (/mm3)-median (IQR)10560 (7705-14305)9120 (7160-11165)12700 (8897-18441)11140 (7870-15810)< 0.001
T-Bil (mg/dL)-median (IQR)99.81 (62.43-155.76)69.28 (49.625-120.975)121.74 (88.97-184.41)1041.2 (67.74-156.31)< 0.001
Albumin (g/L)-median (IQR)35.4 (31.2-39.2)37.5 (34.2-40.4)34.9 (30.8-38.1)33.6 (29.2-37.8)< 0.001
Lactate (mmol/L)-median (IQR)2.15 (1.6-3.4)1.8 (1.4-2.7)2.1 (1.5-2.8)2.4 (1.7-4.1)< 0.001